Shaping the future for cutting edge molecular diagnostics
We helped to make the case for investment in molecular diagnostics, by establishing funding of molecular diagnostics as a test of the Government’s commitment to genomics.
We worked with our client – a trade body – to forge consensus around a new vision for the future of cutting-edge diagnostics and medicines. The constructive solutions we presented secured support from the then Life Sciences Minister. The Government acted, guaranteeing funding for molecular tests, ensuring that no patient would be denied treatment on the basis of lack of funding for diagnostics.